Fig. 1From: Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysisFlowchart showing the procedures in creating a cohort of 1:1 matched-pairs of pioglitazone ever and never users from the reimbursement database of the National Health InsuranceBack to article page